Endo Health to buy Canadian peer Paladin Labs for $1.6 bln

Tue Nov 5, 2013 6:48am EST
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Nov 5 (Reuters) - Specialty pharmaceutical company Endo Health Solutions Inc said it would acquire Canadian peer Paladin Labs Inc for about $1.6 billion to expand its presence in Canada and emerging markets.

Endo will pay C$77 ($73.98) per Paladin share, representing a premium of more than 20 percent to Paladin's Monday close.